文献速递肾癌与肾肿瘤

协作综述:影响局限性实体肾肿块治疗决策的因素

Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass.
PubMed 文献 · Eur Urol · 2021-02-06

该协作综述批判性回顾了局限性非复发性肾细胞癌的治疗选择,识别了监测与治疗、治疗方式(热消融、肾部分切除或根治性肾切除)及手术入路三个关键决策点,并阐述了患者、肾功能、肿瘤和提供者因素对各决策点的影响,强调共享决策和患者决策辅助工具的重要性。

要点

  • 局限性肾细胞癌治疗决策涉及监测与治疗、治疗方式及手术入路三个关键决策点。
  • 患者、肾功能、肿瘤和提供者因素直接或间接影响各决策点。
  • 现有列线图基于预选数据集,前瞻性应用中表现不佳,应谨慎使用。

核心结论

  • 局限性肾细胞癌需要高度精细化的治疗决策,平衡患者和肿瘤特异性临床变量与间接结构性影响以提供最佳患者护理。

研究设计与样本

  • 协作性批判性文献综述。

主要发现

  • 识别了监测与治疗、治疗方式(热消融、肾部分切除或根治性肾切除)及手术入路(开放 vs 微创)三个关键决策点。
  • 患者、肾功能、肿瘤和提供者因素直接或间接影响每个决策点。
  • 当前基于预选患者数据集的列线图在前瞻性环境中表现不佳,应谨慎使用。
  • 患者决策辅助工具在决策过程中使用不足。

临床怎么用

  • 局限性肾细胞癌治疗决策应充分考虑患者、肾功能、肿瘤和提供者因素,并采用共享决策。
  • 患者决策辅助工具可能有助于治疗讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: With the addition of active surveillance and thermal ablation (TA) to the urologist's established repertoire of partial (PN) and radical nephrectomy (RN) as first-line management options for localized renal cell carcinoma (RCC), appropriate treatment decision-making has become increasingly nuanced. OBJECTIVE: To critically review the treatment options for localized, nonrecurrent RCC; to highlight the patient, renal function, tumor, and provider factors that influence treatment decisions; and to provide a framework to conceptualize that decision-making process. EVIDENCE ACQUISITION: A collaborative critical review of the medical literature was conducted. EVIDENCE SYNTHESIS: We identify three key decision points when managing localized RCC: (1) decision for surveillance versus treatment, (2) decision regarding treatment modality (TA, PN, or RN), and (3) decision on surgical approach (open vs minimally invasive). In evaluating factors that influence these treatment decisions, we elaborate on patient, renal function, tumor, and provider factors that either directly or indirectly impact each decision point. As current nomograms, based on preselected patient datasets, perform poorly in prospective settings, these tools should be used with caution. Patient decision aids are an underutilized tool in decision-making. CONCLUSIONS: Localized RCC requires highly nuanced treatment decision-making, balancing patient- and tumor-specific clinical variables against indirect structural influences to provide optimal patient care. PATIENT SUMMARY: With expanding treatment options for localized kidney cancer, treatment decision is highly nuanced and requires shared decision-making. Patient decision aids may be helpful in the treatment discussion.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Chandrasekar T, Boorjian SA, Capitanio U, et al. Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass. Eur Urol. 2021. PMID: 33558091. doi:10.1016/j.eururo.2021.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。